Covance
Home About Covance Investor Relations News Careers Contact Us
Home > Drug Development Services > Clinical > Periapproval Services (Phase IIIb & IV programs) > Services
 Advanced Search
Take me to...
Find a service
Drug Development Services
Nonclinical
Clinical
Commercialization
Industries We Serve
Biotech
Environmental
Food & Dietary Supplements
Pharma
Research
Vaccines
Antibody Products Store
Volunteer for a Study
Investigators
Information Library
Animal Welfare
Periapproval Services
Services
Phase IIIb
Covance — The Natural Selection for Phase IIIb Studies

Covance has helped customers successfully complete more than 140 Phase IIIb studies. We have a wealth of therapeutic knowledge and expertise, and we have established an in-depth clinical understanding by working with both experienced and new investigators. This depth of experience, knowledge and practical expertise has allowed us to creatively tailor our approaches, accelerate study start-up and execute studies in accordance within the stated timelines.

Our Phase IIIb services include:

  • Trials to expand safety and support ongoing filing
  • Registration trials to expand indication
  • Head-to-head trial designs
  • Placebo-controlled trials
  • Cross-over trial designs
Projects are completed efficiently and with effective financial management toward:
  • Addressing important safety and/or efficacy questions remaining after unblinding of pivotal trial data
  • Developing information on the product profile in special patient populations
  • Strengthening your product's safety and tolerability profile under conditions closer to actual practice
  • Building product education
  • Supporting product label changes and providing additional labeling indication
  • Supporting promotional claims and/or reimbursement positioning
Overview
Services
News, Events & Publications
Contact
Industry Links
Periapproval Studies at Covance